SE8004580L - Farmaceutisk beredning - Google Patents

Farmaceutisk beredning

Info

Publication number
SE8004580L
SE8004580L SE8004580A SE8004580A SE8004580L SE 8004580 L SE8004580 L SE 8004580L SE 8004580 A SE8004580 A SE 8004580A SE 8004580 A SE8004580 A SE 8004580A SE 8004580 L SE8004580 L SE 8004580L
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparation
composition
preparation
corticosteroid
minimum
Prior art date
Application number
SE8004580A
Other languages
English (en)
Swedish (sv)
Inventor
K O Bergstrom
J Ulmius
B L T Wenngren
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Priority to SE8004580A priority Critical patent/SE8004580L/xx
Priority to ZA00813465A priority patent/ZA813465B/xx
Priority to FI811745A priority patent/FI811745A7/fi
Priority to EP81850105A priority patent/EP0042827A3/en
Priority to US06/272,881 priority patent/US4363806A/en
Priority to DK262681A priority patent/DK262681A/da
Priority to DD81230895A priority patent/DD159736A5/de
Priority to ES503132A priority patent/ES503132A0/es
Priority to PT73215A priority patent/PT73215B/pt
Priority to NO812075A priority patent/NO812075L/no
Priority to GR65272A priority patent/GR74568B/el
Priority to JP9409781A priority patent/JPS5731700A/ja
Publication of SE8004580L publication Critical patent/SE8004580L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/066—Multiple emulsions, e.g. water-in-oil-in-water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE8004580A 1980-06-19 1980-06-19 Farmaceutisk beredning SE8004580L (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE8004580A SE8004580L (sv) 1980-06-19 1980-06-19 Farmaceutisk beredning
ZA00813465A ZA813465B (en) 1980-06-19 1981-05-22 Pharmaceutical composition
FI811745A FI811745A7 (fi) 1980-06-19 1981-06-04 Farmaseuttinen seos ja menetelmä sen valmistamiseksi.
EP81850105A EP0042827A3 (en) 1980-06-19 1981-06-10 Pharmaceutical composition
US06/272,881 US4363806A (en) 1980-06-19 1981-06-12 Pharmaceutical composition
DK262681A DK262681A (da) 1980-06-19 1981-06-16 Corticosteroidholdigt farmaceutisk praeparat til topical paafoering samt fremgangsmaade til frmstilling deraf
DD81230895A DD159736A5 (de) 1980-06-19 1981-06-17 Verfahren zur herstellung eines pharmazeutischen steroidpraeparates
ES503132A ES503132A0 (es) 1980-06-19 1981-06-17 Un procedimiento de preparacion de una composicion farmaceu-tica de un esteroide
PT73215A PT73215B (en) 1980-06-19 1981-06-17 Process for preparing pharmaceutical steroid compositions for topical application
NO812075A NO812075L (no) 1980-06-19 1981-06-18 Farmasoeytisk preparat, samt fremgangsmaate til fremstilling derav.
GR65272A GR74568B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-06-19 1981-06-18
JP9409781A JPS5731700A (en) 1980-06-19 1981-06-19 Pharmaceutic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8004580A SE8004580L (sv) 1980-06-19 1980-06-19 Farmaceutisk beredning

Publications (1)

Publication Number Publication Date
SE8004580L true SE8004580L (sv) 1981-12-20

Family

ID=20341257

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004580A SE8004580L (sv) 1980-06-19 1980-06-19 Farmaceutisk beredning

Country Status (12)

Country Link
US (1) US4363806A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0042827A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5731700A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD159736A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK262681A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES503132A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI811745A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR74568B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO812075L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT73215B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE8004580L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA813465B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
DE3225849A1 (de) * 1982-07-07 1984-01-19 Schering Ag Kortikoidhaltige zubereitung zur topischen applikation
DE3225848A1 (de) * 1982-07-07 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Kortikoidhaltige zubereitung zur topischen applikation
LU84514A1 (fr) * 1982-12-09 1984-10-22 Oreal Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone
JP2655190B2 (ja) * 1989-06-21 1997-09-17 エスエス製薬 株式会社 コルチコステロイド含有軟膏剤
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
FR2679788B1 (fr) * 1991-08-02 1994-03-18 Thorel Jean Noel Structures d'emulsions polyphasiques autostabilisees.
DE4311445C1 (de) * 1993-04-07 1994-10-06 Henkel Kgaa Multiple W/O/W-Emulsionen, Verfahren zu deren Herstellung und ihre Verwendung
FR2721212B1 (fr) * 1994-06-17 1996-09-13 Pf Medicament Composition et procédé d'obtention d'une émulsion de désonide.
US5589177A (en) * 1994-12-06 1996-12-31 Helene Curtis, Inc. Rinse-off water-in-oil-in-water compositions
ES2118033B1 (es) * 1996-02-16 1999-07-01 Bial Ind Farmaceutica S A Formulacion farmaceutica antiinflamatoria.
US5853740A (en) * 1996-08-07 1998-12-29 Abbott Laboratories Delivery system for pharmaceutical agents encapsulated with oils
GB9823036D0 (en) * 1998-10-22 1998-12-16 Glaxo Group Ltd Fluticasone lotion having improved vasoconstrictor activity
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
CA2502986C (en) 2002-10-25 2011-08-23 Foamix Ltd. Cosmetic and pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
AU2004210436A1 (en) * 2003-02-05 2004-08-19 Galderma Research & Development, S.N.C. Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
FR2850575B1 (fr) * 2003-02-05 2007-04-13 Galderma Res & Dev Composition de type emulsion inverse contenant au moins un actif sensible a la presence d'eau, et ses utilisations en dermatologie
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
NZ624922A (en) * 2009-10-01 2016-05-27 Adare Pharmaceuticals Inc Orally administered corticosteroid compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CA2776471C (en) 2009-10-02 2019-02-12 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
BR122021011439B1 (pt) * 2017-06-12 2022-03-29 Lakewood Amedex, Inc Formulação em gel de bisfosfocina e usos da mesma

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1080994A (en) * 1963-10-25 1967-08-31 Nat Res Dev Injectable emulsions containing antigens
US3395028A (en) * 1966-09-12 1968-07-30 Drackett Co Wax composition and method for making the same
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
US3992534A (en) * 1972-05-19 1976-11-16 Ab Bofors Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods
SE378109B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1972-05-19 1975-08-18 Bofors Ab
US3996359A (en) * 1972-05-19 1976-12-07 Ab Bofors Novel stereoisomeric component A of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steroid 21-acylates, compositions thereof, and method of treating therewith
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
DE2514873C2 (de) * 1975-04-05 1983-12-29 Merck Patent Gmbh, 6100 Darmstadt Salbengrundlage
GB1541463A (en) * 1975-10-11 1979-02-28 Lion Dentifrice Co Ltd Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
US4048310A (en) * 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
US4284630A (en) * 1978-03-22 1981-08-18 Yu Ruey J Stabilized water-in-oil emulsions
US4198403A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
JPS5612307A (en) * 1979-07-09 1981-02-06 Lion Corp External preparation

Also Published As

Publication number Publication date
FI811745L (fi) 1981-12-20
ES8203605A1 (es) 1982-04-16
ES503132A0 (es) 1982-04-16
DD159736A5 (de) 1983-04-06
FI811745A7 (fi) 1981-12-20
US4363806A (en) 1982-12-14
PT73215B (en) 1982-07-22
PT73215A (en) 1981-07-01
DK262681A (da) 1981-12-20
JPS5731700A (en) 1982-02-20
EP0042827A2 (en) 1981-12-30
NO812075L (no) 1981-12-21
GR74568B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-06-29
EP0042827A3 (en) 1983-02-16
ZA813465B (en) 1982-06-30

Similar Documents

Publication Publication Date Title
SE8004580L (sv) Farmaceutisk beredning
NL7613208A (nl) Werkwijze ter bereiding van plantenziekte be- strijdingsmiddelen alsmede preparaten onder toepassing hiervan.
NL190747C (nl) Werkwijze ter bereiding van een geneesmiddel met antitumorwerking en werkwijze ter bereiding van steroid-derivaten die geschikt zijn voor gebruik bij eerstgenoemde werkwijze.
FR2314197A1 (fr) Procede de preparation d'oxo-20 steroides insatures en 9,11
NL190806C (nl) Werkwijze ter bereiding van een farmaceutisch preparaat voor de behandeling van acne en werkwijze ter bereiding van een voor opname in een dergelijk preparaat geschikt retinezuurderivaat.
NL7705095A (nl) Werkwijze voor de bereiding van cosmetische preparaten met een gehalte aan middelen die de huid vochtig houden.
NL7711916A (nl) Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
NL7607572A (nl) Werkwijze voor de bereiding van zuiver druive- zuur en van mesowijnsteenzuur.
ATE44462T1 (de) Betamethazondipropionat-creme.
NL7612239A (nl) Werkwijze ter bereiding van derivaten van dauno- rubicine alsmede preparaten die deze derivaten bevatten.
NL180585C (nl) Werkwijze voor de bereiding van oxim-ethers, alsmede werkwijze voor de bereiding of vervaardiging van farmaceutische preparaten die deze bevatten.
NL7802482A (nl) Preparaat voor de profylaxis en therapie van acne vulgaris en werkwijze voor de profylaxis en therapie van acne vulgaris met behulp van pyridinaldehyden.
DE2961648D1 (en) Corticosteroid anti-inflammatory agents, their use and methods for their preparation
NL7611254A (nl) Werkwijze voor de bereiding van nieuw cyclo- hexylfenyl-derivaten en werkwijze voor de be- reiding van preparaten die ze bevatten.
NL7607494A (nl) Werkwijze ter bereiding van 2-benzopyranonderi- vaten alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten.
IT7948552A0 (it) Composizione farmaceutica anticomplementare e procedimento per produrla ed applicarla
NL165178C (nl) Werkwijze ter bereiding van een therapeutisch preparaat onder toepassing van een 6-fluor-16-methylsteroid van de pregnaanreeks alsmede werkwijze ter bereiding van een daarbij toe te passen steroid en gevormd voort- brengsel.
ATA175378A (de) Verfahren zur herstellung neuer steroid-spiroaxazolidinon-derivate und ihrer stereo-isomere
ZA796194B (en) New 2,2-dimethyl 19-nor steroid derivatives,process for their preparation,their application as medicaments and pharmaceutical compositions containing them
ES491356A0 (es) Metodo para producir preparados medicinales para el trata- miento de carcinomas
NL7702166A (nl) Werkwijze voor de bereiding van 16(alpha)-methylpreg- naan-derivaten en van preparaten die ze bevat- ten.
NL7610761A (nl) Werkwijze voor de bereiding van prostaglandinen en van preparaten die ze bevatten.
NL7603068A (nl) Werkwijze voor de bereiding van analgetische en tegen ontstekingen werkzame stoffen en pre- paraten die ze bevatten.
NL7608307A (nl) Werkwijze voor de bereiding van farmaceutische preparaten voor de bestrijding van huidaan- doeningen.
NL7608308A (nl) Werkwijze voor de bereiding van farmaceutische preparaten voor de bestrijding van huidaan- doeningen.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8004580-0